US experts have discovered the drugs could also reduce the risk of a range weight-related cancers including hard to diagnose types such as of pancreatic and ovarian. US experts have discovered the drugs could also reduce the risk of a range weight-related cancers including hard to diagnose types such as of pancreatic and ovarian.